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Abstract:
To answer the need for the rigorous protection of biomedical data, we organized the Critical Assessment of Data
Privacy and Protection initiative as a community effort to evaluate privacy-preserving dissemination techniques for
biomedical data. We focused on the challenge of sharing aggregate human genomic data (e.g., allele frequencies)
in a way that preserves the privacy of the data donors, without undermining the utility of genome-wide
association studies (GWAS) or impeding their dissemination. Specifically, we designed two problems for
disseminating the raw data and the analysis outcome, respectively, based on publicly available data from HapMap
and from the Personal Genome Project. A total of six teams participated in the challenges. The final results were
presented at a workshop of the iDASH (integrating Data for Analysis, ‘anonymization,’ and SHaring) National Center
for Biomedical Computing. We report the results of the challenge and our findings about the current genome
privacy protection techniques.
Introduction
The biomedical community is evolving to benefit from
and to contribute to big data science. This began with
advances in high throughput and computing technologies
and is expanding to include expected, as well as unex-
pected, sources of health-related data, such as electronic
health records and social media. A large amount of biome-
dical data (e.g., human DNA sequences) are being rapidly
generated in research and clinical laboratories and health-
care settings [1]. Human genome sequencing will soon
become a routine procedure in biomedical research and
healthcare, thanks to the rapidly increasing throughput
and decreasing cost of DNA sequencing techniques.
To transform such data into knowledge that is applic-
able to biomedicine, new technologies for large-scale
investigations and meta-analysis analysis (e.g., [2]) on
genomic data continue to be developed, increasing the
probability that human genomes will be used for clinical
diagnosis and therapy, a trend dubbed “base pairs to
bedside” [3].
However, further progress in this area has been
impeded by the constraints in accessing human genome
data, due in part to privacy concerns related to the dis-
closure of these data [4,5]. As human genome is a type
of biometric identifier, special provisions to protect priv-
acy of individuals need to be taken into account.
It is well known that sharing raw DNA data (e.g., gen-
otypes) poses risks even after the removal of explicit
identifiers (e.g., name and Social Security number.), as
the donor can be possibly re-identified through the
genetic markers (e.g., single nucleotide polymorphisms,
or SNPs) in the data [6-8]. Even aggregated DNA data,
such as allele frequencies, have been found to leak out
identity information [9]. Specifically, Homer et al. [10]
discovered that the presence of an individual in a case
group can be reliably determined from allele frequencies
using the person’s DNA profile. As a result, NIH and
Wellcome Trust removed most aggregated DNA data
from the public domain to protect the privacy of study
participants [11]. Computational approaches have been
developed to characterize which SNPs could be shared
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under the assumption that they are common variants
[12,13]. For example, it was shown that re-identification
is unlikely if the set contains more than 1000 people
[13]. Nonetheless, data owners are becoming more cau-
tious about sharing human genomic data, often imple-
menting additional processes to review proposals for
data access.
In the past several years, there is growing interest in
developing effective methodologies to analyze and disse-
minate sensitive data. Cryptographic protocols (such as
homomorphic computation [14-17]) were developed for
analyzing sensitive data through computation over the
ciphertext. However, these methods provide no protec-
tion to the output of computation, and thus cannot be
directly used for disseminating sensitive data. Data per-
turbation techniques (e.g., [18-20]) achieve privacy pro-
tection on input and/or output data and can be used to
disseminate sensitive data or to publish computing
results that contain sensitive information. A recent
review on privacy preserving technology to support data
sharing for comparative effectiveness research presents
an overview of some of these techniques [21].
A critical challenge of applying privacy technology on
human genomic data is to balance data sharing (and
data utility in real-world genomic analyses in particular)
and privacy protection. To investigate the extent to
which data perturbation technologies are practical, we
organized the Critical Assessment of Data Privacy and
Protection (CADPP) Workshop as a community effort
to evaluate the effectiveness of these methodologies (in
particular differential privacy approaches [20]) for geno-
mic data. This workshop was organized around two spe-
cific problems. For the first problem, teams focused on
the challenge of sharing aggregate human genomic data
(e.g., allele frequencies) to preserve the privacy of the
data donors, without undermining the utility of the data
in genome-wide association studies (GWAS). This
means that, in practice, the most significant genomic
regions identified by a GWAS were preserved after data
perturbation. In the second problem, teams were chal-
lenged to publish GWAS results (i.e., the most signifi-
cant genomic regions) that meet the differentially
privacy criteria under a specific privacy budget.
We devised a task for each of these two problems,
based on publicly available data from the International
HapMap Project [22] and the Personal Genome Project
(PGP) [23]. A total of six teams from two countries
participated in the challenges and submitted their
results to one or both tasks. In this article, we describe
the design of the challenge tasks and our findings.
Two companion papers in this issue of the journal
[22,23] written by participating teams provide details
of the data perturbation techniques that were used in
the challenge tasks.
Background
For both tasks, we challenged teams to apply data per-
turbation techniques based on the differential privacy
standard. These techniques attempt to add noise to the
allele frequencies of the case group so that the resulting
data are indistinguishable when any individual is present
or absent in the case group. Below, we provide back-
ground on differential privacy, a framework developed
by Dwork [20], for readers who are not familiar with
this model.
Definition 1 (ε -Differential Privacy) A randomized
algorithm f satisfies ε -differential privacy if for all
adjacent datasets D and D′ , and any possible output
D̂ in the output space of f ,
Pr[f (D) = D̂]
Pr[f (D’) = D̂]
≤ eε (1)
Note that D̂ can be a dataset or a numerical value (a
differentially private query result such as a statistic)
depending on the application of interest. The Laplacian
mechanism [24] is commonly applied in data perturba-
tion methods to achieve differential privacy. It adds noise
drawn from a Laplacian distribution, Laplace(0,f /ε) , to
the output of a computation on the dataset. The degree
of noise depends on the sensitivity of the computation. In
this model, sensitivity characterizes the maximum change
in the output of a function when elements change in a
dataset.
Definition 2 For any f : D → Rd , and all adjacent
datasets D and D′ , the sensitivity of f is
f = maxD,D′ ||f (D) − f (D′)||1 (2)
Another popular method for achieving differential
privacy is called the exponential mechanism, which was
proposed by McSherry and Talwar [25]. This mechan-
ism chooses an output t ε T that is close to the opti-
mum with respect to a utility function while preserving
the differential privacy definition. The exponential
mechanism takes as input a data set D , an output range
T , a privacy parameter ε, and a utility function
u : (D × T) → R that assigns a real-valued score to
every possible output t ε T , for which a higher score
stands for better utility. The mechanism induces a prob-
ability distribution over the range of T and sample an
output t in proportion to exp




u = maxD,D′ ||u(D) − u(D′)||1 stands for the sensitivity
of the utility function.
Method
As mentioned, we organized the challenge around two
specific problems: i) sharing allele frequencies and
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ii) sharing the most significant single nucleotide variants
(SNVs) in GWAS.
We devised one task for each problem. For each task,
we constructed two datasets based on case and control
groups of individuals. The case group was composed
of the subjects from the Personal Genome Project
(http://www.personalgenomes.org/), which consisted of
411 participants whose genotypes were profiled on
29,757,319 SNVs across the whole genome. The con-
trol data consisted of 174 participants from the CEU
population in HapMap (http://hapmap.ncbi.nlm.nih.
gov/index.html.en).
Task 1: privacy preserving data sharing
The goal of this task is to achieve the highest utility
under the perturbed case-control test statistics (i.e.,
allele frequencies). Each team was provided with the
original allele frequencies for the case group, and was
instructed to submit perturbed allele frequencies for
this group. Note that, in the challenge, we assume the
genotypes of the control group are publicly shared, and
thus there is no need to protect them. In order for par-
ticipating teams to evaluate the effectiveness of their
data perturbation method, the control group data were
made available.
Quantification of privacy risks
Numerous statistical attack models have been proposed
to detect the presence of a participant in a case popula-
tion. Homer et al. presented a statistical inference
approach that computes the likelihood of a patient to
participate in a case group whose aggregate allele fre-
quencies on many SNV were shared [10]. Following this
approach, Sankararaman et al. [13] showed the upper
bound of the power by using the strongest re-identifica-
tion test statistic, i.e., the likelihood ratio (LR) test,







+ (1 − xj)log
1 − pˆj
1 − pj ),
(3)
where xj is the allele type (i.e., 0 for the major allele,
or 1 for the minor allele) at the SNV site j, m is the
total number of SNVs, pj is the minor allele frequency
of SNV j in the case group, and p̂j is the corresponding
number for the reference group.
A statistic L¯i is then computed over all SNV sites for
a subject i, representing the likelihood of that subject’s
presence in the case group. The probability that a sub-
ject in the case group will be re-identified is considered
to be high if the LR test statistic from her SNVs is sig-
nificantly greater than those of subjects who are not in
the case group.
We used the LR test to evaluate the privacy risks in
the submitted data after perturbation from participating
teams. The submitted data were considered sufficiently
protected if there were approximately the same number
of individuals in the case group with LR statistics above
the same threshold as those in a test group (i.e., indivi-
duals not in the case or control groups). The utility of
the perturbed data were measured using the number of
significant SNPs identified by the c2-association test
[26], which is commonly used in GWAS for case and
control groups. A data perturbation method was consid-
ered to have high utility if a majority of the significant
(below a p-value threshold, e.g., 10−5) SNVs reported by
the c2-association test on perturbed data were true. In
other words, these SNVs were identified as truly signifi-
cant on the original data using the same statistical test
and a majority of truly significant SNVs could be identi-
fied on the perturbed data.
We implemented the likelihood ratio test as an online
tool (http://www.humangenomeprivacy.org/service.php)
for participating teams to evaluate the privacy risks in
their perturbed data. A team could upload perturbed
allele frequencies in the case group, and the LR statistics
were calculated for each case individual using his/her
actual genotype, the uploaded allele frequencies in the
case group, and the actual allele frequencies in the con-
trol group (from the HapMap project). For comparison,
the LR statistics were also computed for a group of test
individuals (also from the HapMap project) who were
not in either the case or control group. If the number of
case individuals was not significantly larger than the
number of test individuals who had a test statistic above
a certain threshold, these case individuals were consid-
ered indistinguishable from any individuals outside the
case group and the perturbed case group data were con-
sidered to be privacy-preserving.
We released two datasets for this task. The first data-
set consisted of 311 SNV sites spanning of 5M bps
genomic segment on human chromosome 2, which was
a challenging dataset for which the re-identification risk
could be alleviated (but not fully mitigated) using our
baseline method (see below). The second dataset con-
sisted of 600 SNV sites spanning a 1M bps genomic seg-
ment on human chromosome 10, which is a moderately
challenging dataset whose re-identification risk can be
fully mitigated by our baseline method.
Baseline method
To ensure the feasibility of the competition, we imple-
mented two baseline algorithms for adding noise to data
used in task 1, which we refer to as the naïve and
advanced algorithms. In the naïve algorithm, we treated
the allele counts across multiple SNP sites as a histo-
gram, and added Laplacian noise to the allele counts.
Note that the sensitivity of the count function over N
SNVs is 2N, which can be used inLaplace(0,f /ε) to
determine the amount of noise that needs to be added.
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As the name implies, the naïve algorithm is simple
and straightforward. However, the sensitivity in this case
is high because the dimensionality of the dataset, which
corresponds to the number of SNVs, is large (e.g., sev-
eral hundred in the case of the two datasets used in
challenge 1). The high sensitivity can resulting in adding
a large amount of noise to the data, which may signifi-
cantly damage the utility.
By contrast, the advanced data perturbation algorithm
is designed based on the haplotypes [27], an intrinsic fea-
ture of the human genome. Each copy of the DNA
sequence in a single human genome can be partitioned
into haplotype blocks (or haploblocks); within each block,
a specific combination of alleles across multiple adjacent
SNV sites is called a haplotype. Due to linkage disequili-
brium (LD) in human, SNVs within each block are likely
inherited together. As a result, inter-haploblock SNVs
are more highly correlated than intra-haploblock SNVs.
Therefore, the number of potential SNV sequences in
each haplotype block (across n SNV sites) is much smal-
ler than the theoretical bound (i.e., 2n ). Notably, the hap-
lotype block structure of the human genome can be
inferred from public data, which are independent from
the sensitive case data to be protected [27].
Figure 1 shows the first three haploblocks of dataset 1
that were used in task 1. The SNV sites and the haplo-
types are shown below the haploblock ID. The numbers
next to each haplotype represent their observed frequen-
cies in the CEU population of the HapMap project. The
solid lines between haplotypes from adjacent haploblocks
represent the most common combinations between the
haplotypes. The thickness of the line represents the fre-
quencies of the corresponding combinations. From the
figure, it can be seen that about 50% of all SNV
sequences contain the combination of haplotypes
ACCGTGA in the first two haplotype blocks, and the
third haplotype block consists of 125 SNVs, but has only
17 common haplotypes (instead of the theoretical upper
bound of 2125). Rather than adding noise to allele counts
on individual SNV sites, the advanced data perturbation
approach adds Laplacian noise to the haplotype counts,
which are normalized within each haplotype block.
We derived the allele counts on each SNV site from
counts of haplotypes containing the site. By using haplo-
types, we can reduce the dimensionality of genomic data
by one order of magnitude. In practice, we need to allo-
cate the privacy budget (default 1) into haploblocks in an
unequal manner to ensure it is not overspent. To do so,
we employed an empirical method for budget allocation.
Specifically, we allocated a budget to each haploblock
proportionally to the number of haplotypes within that
block. In doing so, a larger budget will be assigned to the
blocks with a greater number of haplotypes (and thus
less noise will be added to them). Similarly, a smaller
budget will be assigned to the blocks with fewer haplo-
types. Note that the total privacy budget across the entire
dataset remains the same as in the naïve approach.
Challenge datasets and utility evaluation
We constructed two datasets for Challenge 1. The first
case dataset consists of 311 SNVs from 200 PGP partici-
pants. As shown in Figure 2(a), the SNVs span 14 conse-
cutive haplotype blocks in one genomic locus from
29504091 to 30044866 on human chromosome 2. The
control and test datasets comprise the corresponding
SNVs from 174 HapMap CEU individuals, which are pub-
licly available.
Figure 3(a) shows the p-value distribution, based on a
c2 test, of all SNVs in this this case-control dataset. The
upper and lower lines in the figure differentiate the top-5
and top-10 most significant SNVs, respectively, from the
rest of the set, which correspond to the p-value cutoffs of
10−8 and 10−7, respectively. The practical p-value thresh-
old used in GWAS is 10−5, indicating that there exist
many significant SNVs in the dataset to be identified in
typical GWAS analyses.
The second case dataset consists of 610 SNVs of the
same 200 participants from the PGP as the first dataset.
As shown in Figure 2(b), these SNVs span over 21 conse-
cutive haplotype blocks, which are in one genomic locus
from 55127312 to 56292137 on human chromosome 10.
Figure 1 The haploblock structure in the first dataset used in task 1.
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The control dataset is comprised of the corresponding
SNVs from the 174 HapMap CEU individuals. Figure 3
(b) shows the different levels of significance according to
the c2-association test on this dataset. Figure 4 shows the
file format of the data for task 1 that were provided to
participating teams (available at http://www.humangen-
omeprivacy.org/competitiondata.php). The first line of
the file consists of the IDs of human individuals, followed
by the SNV ID and the genotypes in each individual,
which themselves follow the order of SNV site locations.
The allele frequencies for the SNVs can be derived from
the input data. To evaluate the utility of the perturbed
case data submitted by participating teams, we conducted
a c2 test on a combination of the submitted and unper-
turbed control data. The significant SNVs (i.e., p-value
below a threshold of 10−5) were compared to the signifi-
cant SNVs reported by the same test on the un-perturbed
case data. A larger number of common SNVs between
these sets indicates higher utility of the corresponding
perturbation technique and vice versa.
Task 2: secure release of analysis results
The goal of the second task was to evaluate the utility of
competing data perturbation techniques in releasing
privacy protected results of GWAS. We consider a typi-
cal GWAS, where the users are interested in knowing
the identity of the top-K (e.g., K = 1, 5 or 10) most sig-
nificant SNVs among all SNVs (for the statistical test)
across the genome. Again, we used the c2 test statistic
for utility evaluation in the case-control analysis. We
expected the released GWAS results to achieve a given
privacy standard: they should be differentially private
with a privacy budget of 1. The utility of the anon-
ymized GWAS results submitted by the participating
groups was evaluated based on the proportion of SNVs
in the released result that were among actual top-K
most significant SNVs that would have been released if
preserving privacy was not a concern.
We first preprocessed the case data containing
29,755,199 SNV sites to make them compatible with the
control data. Many SNV sites were genotyped for only a
small portion of PGP individuals, and some other SNV
sites genotyped in PGP were not genotyped in HapMap.
We removed all unmatched SNV data between these two
datasets and retained only the valid 2,500,781 SNV sites
genotyped in at least 174 PGP participants so that we
could estimate the allele frequencies on these sites accu-
rately. Next, we eliminated PGP participants from our
Figure 2 The haploblock structure in the datasets used in task 1. (a) The haploblock structure for dataset 1. (b) The haploblock structure for
dataset 2.
Figure 3 The p-value distributions based on a c2 test (a) The p-value distribution for dataset 1. (b) The p-value distribution for dataset 2.
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constructed dataset who had fewer than 90,000 geno-
typed valid SNV sites. After these preprocessing steps,
there were still genotypes missing for some PGP partici-
pants, which were imputed based on allele frequencies
from the CEU population in HapMap using fastPHASE, a
commonly utilized phasing tool [28]. Finally, we con-
structed the case group consisting of 201 PGP partici-
pants, and a control group consisting of 174 HapMap
CEU participants, both genotyped on the same set of
106,129 SNV sites.
We constructed two datasets for this task. The large
dataset consists of all valid 106,129 SNVs from 201 cases
and 174 controls after the data pre-processing procedure,
which was used to evaluate the utility of the perturbation
algorithms submitted by participating teams. We also
constructed a small dataset (a subset of the larger one)
consisting of 5000 SNVs on the same case and control
groups that were randomly sampled from the larger data-
set. The SNVs in both datasets were evenly distributed in
different human chromosomes (Figure 5), indicating that
this represented a good training set for participating
teams to test their algorithms.
WIDGET: a web interface for dynamic genome-privacy
evaluation
We built a companion webservice using JavaScript and R
Shiny server technology (http://shiny.rstudio.com/) to
dynamically compare the algorithms of participating
teams that can be accessed at https://humangenomepriv-
acy.ucsd-dbmi.org. Using this webservice, a user can
assess competing models in finer granularity than what is
reported in this article. The figures below illustrate how
WIDGET can be used to evaluate a model’s performance
for task 1 and task 2, respectively.
Figure 6(a) shows boxplots indicative of the accuracy of
different privacy-preserving synthetic data generation algo-
rithms (Task 1). In addition to accuracy, users can check
other metrics (e.g., true positive rate, false positive rate,
and F1), which are listed under the boxplot. In Figure 6(b),
we illustrate the privacy risk using the LR test based on a
given significant level. Users can compare multiple results
at a time, where identified and non-identified individuals
are illustrated with different markers. Users can adjust the
significance level in their studies and any change is dyna-
mically updated in the boxplots.
In Figure 7, we show how to use WIDGET to compare
three methods and K values (up to 9) for top-K SNV
identification (Task 2), where the same privacy standard
(i.e., ∈= 1) was used for all cases. Figure 7(a) depicts the
number of SNVs identified by three methods under K =
15. Figure 7(b) illustrates the top-K (e.g., 1, 3, 5, ..., 50)
SNV identification performance of a given method.
Results and discussions
A total of six teams participated in the competition.
Three teams, from the University of Oklahoma, Univer-
sity of Texas (UT) Dallas, and McGill University, partici-
pated in the first task. The team from Indiana University
collaborated with the UCSD organizers to design and
implement the baseline methods, but they did not parti-
cipate in the competition. Two teams, from UT Austin
and Carnegie Mellon University, participated in the sec-
ond task. The results of the challenge were presented at
an iDASH (a National Center for Biomedical Computing
Figure 4 A snapshot of the dataset released for task 1.
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based at UCSD) workshop on March 24, 2014 in La Jolla,
California. All teams presented their methods and results
at the workshop. The details of the methods used in
the challenge are described in separate articles in this
issue [29,30]. Below, we summarize the results of the
challenge and our own findings.
Table 1 shows the results of the evaluation methods
for task 1. The privacy risk in the perturbed data was
measured using the power of the LR test; i.e., the frac-
tion of case individuals who could be re-identified with
confidence higher than a specified threshold. If the
power was not significantly higher than 0.05, we consid-
ered the perturbed data to have a small privacy risk.
From the results, we can see that in all cases except two
(including the haplotype-based method on the second
dataset), the privacy risk was sufficiently mitigated by
the data perturbation techniques. We then measured
the utility of the perturbed data based on the number of
significant SNVs detected by using c2 test (see above)
under various p-value cutoffs (0.05, 0.001, and 0.00001)
of a c2test.
The results of the SNV-based algorithm (the naïve
baseline method) showed the least utility. It missed a
substantial number of truly significant SNVs, while it
generated a large number false positive SNVs. The hap-
lotype-based algorithm exhibited better performance.
Almost all truly significant SNVs were detected in both
datasets, and the number of false positives was reduced.
The results of UT Dallas and McGill University teams
showed similar results on utility of perturbed data, and
nearly all significant SNVs were detected, although both
had a high false positive rate. Overall, the McGill Uni-
versity team performed the best in the task and won the
task 1 challenge.
Figure 5 The number of SNVs sampled from chromosomes. (a) The number-sampling distribution for the large dataset. (b) The number-
sampling distribution for the small dataset.
Figure 6 Evaluation results for task 1: (a) data utility and (b) privacy evaluation through WIDGET.
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Table 2 summarizes the findings from task 2. Notably,
both teams achieved impressive performance levels. For
the small dataset, when K is set to be smaller than 15,
both algorithms can correctly identify more than 80% of
the top-K most significant SNVs. The performance is,
however, inversely correlated with K, such that when K
≥ 15, both methods return only around 50% of the true
top-K SNVs. Similarly, for the large dataset, when K <
10, both algorithms perform well.
Overall, the UT Austin team generated the best results.
One reason is that their Hamming distance based utility
function had relatively smaller sensitivity (therefore
reduced perturbation noise) when compared to that of the
c2 test statistics used by the CMU team. From the results
of task 1, we observed that it remains a challenge to share
aggregate human genomic data in a privacy-preserving
manner while maintaining truthful associations between
the SNV data and the case-control groups. Even for a sin-
gle genomic locus consisting of a few hundreds of SNVs
the association was largely broken after data perturbation.
This problem will become more challenging as larger
volumes of human genomic data are planned for
dissemination. The performance of differential privacy-
based data perturbation techniques heavily relies on the
dimensionality of the data. Even though we can reduce
the number of dimensions by utilizing unique semantics
of genomic data, such as haplotype blocks, it is unlikely
that current perturbation techniques will scale well for
sharing whole human genomic data.
On the other hand, the results in task 2 showed that
privacy-preserving techniques work well for sharing ana-
lytical results (by using statistics commonly used in
GWAS). High utility can be preserved when only a
small number (e.g., 5-10) of the most significant SNVs
are of interest to the end users. Notably, this task is well
aligned with the centralized computing model, in which
a computing center hosts genomic data, as well as the
service of customized analyses on these data, and will
only release the results of these analyses [31].
Conclusion
It is essential to develop new privacy-preserving techni-
ques that enable the sharing of human genomic data in a
way that preserves the privacy of the data donors,
Figure 7 Evaluation results for task 2: (a) comparison of different methods for a given K in the top-K SNV identification challenge; (b)
comparison of different top-K SNV identification performance of a given method.
Table 1 Results of Task 1
Baseline Team 1 Team 2 Team 3 # of sig SNVs



































































In the first column, D1 refers to 200 participants, 311 SNVs (~29504091-30044866, chr2) and D2 refers to 200 participants, 610 SNVs (~55127312-56292137,
chr10). The rows labeled ‘Power’ indicate the ratio of identifiable individuals using the likelihood ratio test in the case group. The other rows start with a cutoff
threshold for the c2test (e.g., 5 × 10-2, 10-3, 10-5), for which two measurements (true positive rate and false positive rate for SNVs using the c2 test) were
calculated under each method. The last column corresponds to the number of significant SNVs calculated using the original data (i.e., without added noise).
Jiang et al. BMC Medical Informatics and Decision Making 2014, 14(Suppl 1):S1
http://www.biomedcentral.com/1472-6947/14/S1/S1
Page 8 of 10
without undermining the utility of the data or impeding
its convenient dissemination. This workshop only
focused on technical aspects of privacy, but there are
many other components, such as social and legal con-
trols, that need to be accounted for when erecting privacy
preserving infrastructures. As an initial step to assess
existing techniques, we organized the first challenge with
two tasks based on real-world human genomic data in
GWAS. We discovered that differential privacy-based
data perturbation techniques have limitations in sharing
a large volume of human genomic data, but can be used
to disseminate analytical results (by using GWAS-like
statistics), through services like those offered by NCBI.
We plan to organize this challenge annually, and hereby
welcome suggestions and comments to improve the con-
test in upcoming years.
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